Pediatric “5 Ts” (Cyanotic CHD) #4: Tetralogy of Fallot — “Tetra-logy”

Tetralogy of Fallot (TOF) is defined by the classic combination of (1) an anterior malalignment ventricular septal defect, (2) overriding of the aorta, (3) right ventricular outflow tract obstruction, and (4) right ventricular hypertrophy [1]. These findings are not four independent abnormalities. They represent an anatomically interconnected spectrum produced primarily by malalignment of the ventricular outlet septum, with the clinical phenotype determined largely by the location and severity of right ventricular outflow tract obstruction (RVOTO) [1,2].

The central physiologic consequence is competition between pulmonary and systemic ejection from the right ventricle. Because the VSD is usually large and nonrestrictive, right and left ventricular systolic pressures are approximately equal. Increasing RVOTO therefore redirects progressively more right ventricular output across the VSD into the overriding aorta, reducing pulmonary blood flow and producing systemic desaturation.

1. The Classic Quartet

1.1 Anterior Malalignment Ventricular Septal Defect

The VSD in classic TOF is typically a large outlet malalignment VSD beneath the overriding aortic root. Anterior and cephalad displacement of the outlet, or infundibular, septum prevents normal alignment with the remainder of the ventricular septum and creates the characteristic defect.

Because the VSD is generally nonrestrictive, it does not behave physiologically like a small isolated VSD. Instead, it provides a low-resistance communication between ventricles and allows the right ventricle to eject into the systemic circulation when resistance through the pulmonary outflow becomes high.

Surgically, the VSD is central to intracardiac repair. Patch closure must establish an unobstructed left ventricle-to-aorta pathway while respecting the relationships among the aortic valve, tricuspid valve, membranous septum, and atrioventricular conduction axis. The anatomy of the posteroinferior VSD margin is therefore particularly important during suture placement.

1.2 Overriding Aorta

The aortic root is displaced rightward relative to the ventricular septum and receives blood from both ventricles. This relationship constitutes the overriding aorta.

In classic TOF, aortic override is conventionally less than approximately 50%, although the transition between TOF and double-outlet right ventricle represents a morphologic continuum rather than an absolute geometric boundary.

An important anatomic feature is preservation of aorto-mitral continuity. The posterior aortic root remains in fibrous continuity with the mitral valve, whereas the pulmonary outlet lies anteriorly. Thus, rightward displacement of the aorta and anterior displacement of the pulmonary outflow are components of the same outlet malalignment process.

The extent of aortic override alone does not determine cyanosis. The dominant physiologic variable is the resistance imposed by the RVOT.

1.3 Right Ventricular Outflow Tract Obstruction

RVOTO is the most important determinant of the clinical physiology of TOF. Its anatomy is highly variable and may involve multiple levels [2,3].

Obstruction may include:

• Subvalvar or infundibular obstruction, related to anterior displacement of the outlet septum and hypertrophied muscular structures
• Pulmonary valvar stenosis or dysplasia
• Pulmonary annular hypoplasia
• Supravalvar or main pulmonary artery narrowing
• Branch pulmonary artery stenosis or hypoplasia

Contemporary surgical planning therefore requires assessment of the entire RVOT–pulmonary valve–pulmonary artery complex, rather than treating RVOTO as a single anatomic lesion [3,4].

Subvalvar obstruction may also have a dynamic muscular component. Increased catecholamine activity can intensify infundibular contraction and transiently increase resistance to pulmonary blood flow. This phenomenon contributes to the physiology of hypercyanotic spells.

At the mild end of the spectrum, pulmonary blood flow remains sufficient and the infant may have little resting cyanosis. At the severe end, critical RVOTO or pulmonary atresia can make pulmonary circulation dependent on ductal or collateral blood flow.

1.4 Right Ventricular Hypertrophy

Right ventricular hypertrophy is principally a secondary response to chronic pressure loading.

Because the VSD is large, the right ventricle is exposed to near-systemic systolic pressure. The additional resistance created by RVOTO further increases RV workload. Hypertrophy therefore develops as a physiologic consequence of the underlying outlet anatomy rather than as the initiating lesion.

2. A Unified Anatomic Mechanism

The classic quartet can be understood as the downstream expression of anterior and cephalad malalignment of the outlet septum.

This malalignment:

1. Creates the outlet VSD by failing to align with the ventricular septal crest.
2. Narrows the subpulmonary outflow tract.
3. Produces relative rightward displacement and override of the aortic root.
4. Exposes the right ventricle to systemic pressure, ultimately producing hypertrophy.

This concept is more useful surgically than memorizing four independent abnormalities. TOF is fundamentally an outlet malalignment lesion associated with a variable spectrum of RVOTO.

3. Hemodynamic Physiology

Because the VSD is generally nonrestrictive, ventricular systolic pressures tend to equalize. The direction of flow is therefore governed predominantly by the relative impedance of the pulmonary and systemic pathways.

With relatively mild RVOTO, a substantial proportion of RV output reaches the pulmonary arteries. Such patients may have little cyanosis and have historically been described as having a “pink” TOF phenotype.

As RVOTO increases, pulmonary blood flow falls. Right ventricular blood is increasingly directed through the VSD into the overriding aorta, creating a right-to-left shunt and systemic arterial desaturation [1,2].

The fundamental relationship is therefore:

Increasing RVOTO → decreasing pulmonary blood flow → increasing right-to-left shunting → worsening systemic desaturation.

This explains why patients sharing the same diagnostic quartet can present with markedly different degrees of cyanosis.

4. Hypercyanotic “Tet” Spells

A hypercyanotic spell represents an acute deterioration in this physiology, characterized by abrupt reduction in pulmonary blood flow and increased right-to-left shunting.

Potential triggers include agitation, crying, feeding, pain, fever, dehydration, and anesthetic conditions that reduce systemic vascular resistance. Increased sympathetic activity can intensify dynamic infundibular obstruction, while lower systemic vascular resistance favors ejection from the right ventricle across the VSD into the aorta.

A self-amplifying cycle may develop:

Increased RVOT obstruction → reduced pulmonary flow → increased right-to-left shunting → hypoxemia → catecholamine release → further infundibular contraction.

Management is directed at reversing these hemodynamic mechanisms: improving preload, increasing systemic vascular resistance, reducing catecholamine-driven infundibular contraction, and restoring pulmonary blood flow. Oxygen, volume administration, sedation, systemic vasoconstrictors, and beta-blockade may therefore be used according to the clinical situation. Severe or recurrent spells strengthen the indication for definitive intervention.

5. Preoperative Anatomic Assessment

Preoperative imaging must define the anatomy that determines both clinical severity and operative strategy.

Particular attention should be paid to:

• Severity and level of RVOTO
• Pulmonary valve leaflet morphology
• Pulmonary annular dimensions
• Main and branch pulmonary artery size
• VSD morphology and margins
• Degree of aortic override
• Coronary artery anatomy
• Aortic arch sidedness
• Associated intracardiac lesions

The degree of RVOTO and branch pulmonary artery development are particularly important determinants of management [3]. Coronary anatomy is also critical because a major coronary artery crossing the anterior RVOT may limit conventional ventriculotomy-based reconstruction and require modification of the operative approach.

6. Timing of Repair and Initial Palliation

The goal of contemporary management is complete repair while minimizing the long-term consequences of both residual obstruction and surgical disruption of the pulmonary valve and right ventricle.

The supplied evidence does not establish a single definitive age or physiologic threshold for repair. Rather, timing is individualized according to clinical status, severity and location of RVOTO, pulmonary artery anatomy, cyanosis, and associated lesions, ideally through multidisciplinary decision-making [3,5].

Patients with severe neonatal RVOTO may require early intervention. If pulmonary blood flow is ductal dependent, prostaglandin therapy may be needed while a definitive strategy is determined.

In selected high-risk neonates, staged palliation may be chosen instead of immediate complete repair. Strategies can include systemic-to-pulmonary shunting, ductal stenting, or RVOT-directed palliation. The appropriate approach depends on patient size, pulmonary artery anatomy, RVOT morphology, coronary anatomy, and institutional experience.

7. Principles of Complete Surgical Repair

Complete repair has two fundamental objectives:

1. Close the VSD and commit left ventricular output entirely to the aorta.
2. Relieve RVOTO sufficiently to establish adequate pulmonary blood flow without creating excessive pulmonary valve insufficiency.

The first objective is generally achieved with patch closure of the VSD.

The second is more individualized because RVOT and pulmonary-valve morphology vary substantially among patients [4]. Surgical maneuvers may include infundibular muscle resection, pulmonary valvotomy, commissurotomy, main pulmonary artery augmentation, limited RVOT patching, or enlargement across the pulmonary annulus.

Contemporary surgical strategy increasingly emphasizes pulmonary valve preservation whenever adequate relief of obstruction can be achieved safely [3,5].

8. Pulmonary Valve-Sparing Repair Versus Transannular Patch

Preservation of pulmonary valve competence is desirable because chronic free pulmonary regurgitation can impose substantial long-term RV volume loading.

In a series of 102 patients, Stewart and colleagues achieved a pulmonary valve-sparing repair in approximately 80% of patients. Valve preservation was strongly associated with a pulmonary annular z-score of −4 or greater, tricuspid pulmonary-valve morphology, and a postoperative RV-to-LV pressure ratio below 0.7 [6]. Among patients with annular z-scores greater than −4, valve-sparing repair was achieved substantially more frequently than among those with smaller annuli [6].

These findings provide useful anatomic guidance, but they should not be interpreted as universal operative thresholds. The adequacy of a valve-sparing repair depends on the combined morphology of the annulus, leaflets, infundibulum, and pulmonary arteries and on the residual RV pressure after reconstruction.

If sufficient relief cannot be achieved while preserving the annulus, a transannular patch (TAP) may be necessary. A TAP provides effective relief of RVOTO but usually creates important pulmonary regurgitation. Thus, the operative trade-off is between residual RV pressure load and chronic pulmonary volume load.

9. Early Postoperative Physiology

After repair, important residual or early postoperative problems include RV dysfunction, residual RVOTO, pulmonary insufficiency, low cardiac output, arrhythmias, residual intracardiac shunts, and valve-related abnormalities [7].

RV diastolic physiology may be particularly complex. Restrictive RV physiology—classically identified by antegrade pulmonary arterial flow during late diastole—was present in 38% of patients in one mid-term study and occurred more commonly after transannular patch repair than after non-TAP reconstruction [8]. Interestingly, restrictive physiology was associated with less QRS prolongation and potentially fewer later complications, despite potentially complicating the early postoperative course [8].

These observations illustrate that postoperative RV physiology cannot be assessed solely by systolic pressure or ejection fraction; diastolic properties and interaction with pulmonary regurgitation are also important.

10. Long-Term Consequences of Repair

Modern TOF repair provides excellent survival, but repair does not eliminate lifelong cardiovascular risk. The focus of contemporary management has therefore shifted from operative survival toward preservation of RV function and reduction of late reintervention [9].

Important late problems include:

• Pulmonary regurgitation
• Residual or recurrent RVOTO
• Progressive RV dilatation
• RV systolic or diastolic dysfunction
• Tricuspid regurgitation
• Residual VSD
• Aortic root dilatation and aortic regurgitation
• Atrial and ventricular arrhythmias
• Exercise limitation
• Need for pulmonary valve or RVOT reintervention

Across published series summarized in a contemporary review, 30-year survival ranges from approximately 68.5% to 90.5%, demonstrating excellent long-term survival but persistent late morbidity [10]. Residual RVOTO, pulmonary regurgitation, ventricular dysfunction, ventricular arrhythmias, and reinterventions remain important issues [10].

Chronic pulmonary regurgitation is particularly relevant after transannular reconstruction. Progressive RV volume loading may lead to RV enlargement, impaired function, electrical remodeling, and arrhythmia. Recognition of these late consequences has driven increased emphasis on pulmonary valve preservation during primary repair and careful timing of later pulmonary valve intervention [9,10].

11. Clinical Concept: TOF Is Primarily a Pulmonary Blood Flow Problem

The classic quartet provides a useful anatomic framework, but the most important physiologic concept is that clinical severity is primarily determined by the resistance between the right ventricle and pulmonary arteries.

The large VSD gives the right ventricle two potential ejection pathways: through the RVOT toward the lungs or across the VSD into the overriding aorta. As the pulmonary pathway becomes progressively more obstructed, systemic ejection becomes increasingly favorable and cyanosis worsens.

Therefore, when evaluating a patient with TOF, the key question is not simply whether the four components are present. It is:

How obstructed is pulmonary blood flow, where is the obstruction located, and what reconstruction will provide durable relief while preserving right ventricular and pulmonary valve function?

Key Takeaways

• TOF consists of malalignment VSD, overriding aorta, RVOTO, and RV hypertrophy.
• The quartet largely reflects anterior and cephalad malalignment of the outlet septum.
• RVOTO may be subvalvar, valvar, supravalvar, or involve the pulmonary arteries, and its severity is the principal determinant of cyanosis.
• Increasing RVOTO redirects blood right-to-left across the nonrestrictive VSD into the overriding aorta.
• Timing and surgical strategy should be individualized according to clinical status, RVOTO morphology, and pulmonary artery anatomy.
• Complete repair requires VSD closure and adequate relief of RVOTO.
• Pulmonary valve preservation is preferred when it can achieve an acceptable residual RV pressure.
• A transannular patch effectively relieves obstruction but commonly produces chronic pulmonary regurgitation.
• Contemporary surgical goals extend beyond early survival to preservation of RV function, pulmonary valve competence, and freedom from reintervention across the lifespan.
• Lifelong surveillance remains necessary because pulmonary regurgitation, residual obstruction, RV dysfunction, arrhythmias, and reintervention remain important late sequelae.

References

[1] Huehnergarth KV, Gurvitz M, Stout KK, Otto CM. Repaired tetralogy of Fallot in the adult: monitoring and management. Heart. 2008. doi:10.1136/hrt.2008.147249.

[2] van Doorn C. The unnatural history of tetralogy of Fallot: surgical repair is not as definitive as previously thought. Heart. 2002. doi:10.1136/HEART.88.5.447.

[3] Vanderlaan RD, Barron D. Optimal surgical management of tetralogy of Fallot. CJC Pediatric and Congenital Heart Disease. 2023. doi:10.1016/j.cjcpc.2023.09.003.

[4] Boni L, García E, Aguilar JM, Nuila LM, Melo M. Tetralogy of Fallot repair: surgical approach to RVOTO. Pediatric Cardiology and Cardiac Surgery. 2017. doi:10.24509/JPCCS.170107.

[5] Karl T, Stocker C. Tetralogy of Fallot and its variants. Pediatric Critical Care Medicine. 2016. doi:10.1097/PCC.0000000000000831.

[6] Stewart R, Backer C, Young L, Mavroudis C. Tetralogy of Fallot: results of a pulmonary valve-sparing strategy. Ann Thorac Surg. 2005. doi:10.1016/J.ATHORACSUR.2005.04.016.

[7] Forman J, Beech R, Slugantz L, Donnellan A. A review of tetralogy of Fallot and postoperative management. Crit Care Nurs Clin North Am. 2019. doi:10.1016/J.CNC.2019.05.003.

[8] Norgård G, Gatzoulis M, Moraes F, Lincoln C, Shore D, Shinebourne E, Redington A. Relationship between type of outflow tract repair and postoperative right ventricular diastolic physiology in tetralogy of Fallot: implications for long-term outcome. Circulation. 1996. doi:10.1161/01.CIR.94.12.3276.

[9] Bové T, François K, De Wolf D. New insights into the surgical management of tetralogy of Fallot: physiological fundamentals and clinical relevance. Curr Pediatr Rev. 2015. doi:10.2174/1573396311666150702103756.

[10] van der Ven JVD, van den Bosch E, Bogers A, Helbing W. Current outcomes and treatment of tetralogy of Fallot. F1000Research. 2019. doi:10.12688/f1000research.17174.1.